NeuroAge Therapeutics provides comprehensive AI-powered cognitive testing that integrates online assessments, blood biomarkers, genetics, and MRI data. This analysis determines an individual's brain aging rate to assess future risk for neurodegenerative diseases like Alzheimer's and Parkinson's. The company then delivers personalized recommendations aimed at slowing brain aging and developing tailored therapeutics for neurodegeneration.
Funding
$200K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
ASFounders
Product
Problem
The aging process increases the risk of neurodegenerative diseases like Alzheimer's and Parkinson's, impacting cognitive function and overall brain health. Current methods for assessing brain aging are often limited, hindering early detection and personalized intervention strategies.
Solution
NeuroAge Therapeutics offers a comprehensive brain-aging assessment platform that utilizes artificial intelligence to analyze cognitive test results, blood biomarkers, genetic data, and MRI scans. By integrating these diverse data sources, NeuroAge provides individuals with a personalized "brain age" metric and identifies potential risks for future neurodegenerative conditions. The platform then generates tailored recommendations, including lifestyle adjustments and potential therapeutic interventions, designed to slow down or even reverse the biological processes of brain aging. This approach enables proactive management of cognitive health and facilitates the development of targeted therapeutics for age-related neurological disorders.
Target Audience
The primary target audience includes individuals concerned about their cognitive health and risk of neurodegenerative diseases, as well as clinicians and researchers focused on developing and implementing interventions to promote healthy brain aging.
Features
- AI-powered analysis of cognitive performance through online NeuroGames
- Integration of blood biomarker data to identify age-related physiological changes
- Genetic risk assessment for predisposition to neurodegenerative diseases
- Quantitative analysis of brain MRI scans to detect structural changes
- Personalized "brain age" calculation and risk stratification
- Neuprint Protocol: Personalized brain health tele-coaching with a skilled therapist with a degree in Neuroscience from MIT.
- Lifestyle recommendations based on the "Nine Pillars of Health Brain Aging"
- Identification of potential therapeutic targets for reversing brain aging